PFM Health Sciences’s argenx ARGX Stock Holding History

PFM Health Sciences’s Portfolio ARGX Stock Details ARGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.31M	Buy	4,535 +333	+8%	+$261K	0.3%	72
2025 Q4	$3.53M	Sell	4,202 -2,201	-34%	-$1.88M	0.35%	63
2025 Q3	$4.72M	Sell	6,403 -834	-12%	-$550K	0.36%	54
2025 Q2	$3.99M	Sell	7,237 -61,762	-90%	-$35.8M	0.34%	44
2025 Q1	$40.8M	Buy	68,999 +5,300	+8%	+$3.34M	2.97%	11
2024 Q4	$39.2M	Sell	63,699 -23,133	-27%	-$13.6M	2.43%	12
2024 Q3	$47.1M	Hold	86,832	–	–	2.67%	11
2024 Q2	$37.3M	Hold	86,832	–	–	1.85%	18
2024 Q1	$34.2M	Hold	86,832	–	–	1.61%	22
2023 Q4	$33M	Sell	86,832 -17,900	-17%	-$8.34M	1.98%	18
2023 Q3	$51.5M	Hold	104,732	–	–	2.43%	11
2023 Q2	$40.8M	Hold	104,732	–	–	1.58%	30
2023 Q1	$39M	Hold	104,732	–	–	1.72%	23
2022 Q4	$39.7M	Hold	104,732	–	–	1.42%	29
2022 Q3	$37M	Hold	104,732	–	–	1.34%	35
2022 Q2	$39.7M	Buy	+104,732	New	+$33.7M	1.51%	26
2019 Q1	–	Sell	-117,834	Closed	-$11.3M	–	96
2018 Q4	$11.3M	Buy	+117,834	New	+$10.5M	0.3%	68

Other funds holding ARGX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's ARGX Position: Q1 2026 in Review

PFM Health Sciences increased its argenx (ARGX) stake by 7.9% in Q1 2026, buying an estimated $261K and bringing the position to 4,535 shares worth $3.31M. The position accounts for 0.3% of the portfolio, ranked #72.

PFM Health Sciences first reported a position in ARGX in Q4 2018 and has held it in 17 quarters since. The position peaked at $51.5M in Q3 2023. 475 funds tracked by Wall St. Rank hold ARGX as of Q1 2026.

PFM Health Sciences held 4,535 shares of argenx worth $3.31M as of Q1 2026.
PFM Health Sciences bought 333 argenx shares in Q1 2026, an estimated $261K.
argenx made up 0.3% of PFM Health Sciences's portfolio in Q1 2026, its #72 holding.
PFM Health Sciences first reported a position in argenx in Q4 2018 and has held it in 17 quarters since.
PFM Health Sciences's argenx position peaked at $51.5M in Q3 2023.
475 funds tracked by Wall St. Rank held argenx as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.